Contrasting HWH International (NASDAQ:HWH) & Chugai Pharmaceutical (OTCMKTS:CHGCY)

HWH International (NASDAQ:HWH) and Chugai Pharmaceutical (OTCMKTS:CHGCY) are both consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Risk & Volatility

HWH International has a beta of -1.47, suggesting that its share price is 247% less volatile than the S&P 500. Comparatively, Chugai Pharmaceutical has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for HWH International and Chugai Pharmaceutical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HWH International	0	0	0	0	N/A
Chugai Pharmaceutical	0	0	0	0	N/A

Earnings & Valuation

This table compares HWH International and Chugai Pharmaceutical’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HWH International	N/A	N/A	$550,000.00	N/A	N/A
Chugai Pharmaceutical	$7.93 billion	8.28	$2.31 billion	$0.68	29.34

Chugai Pharmaceutical has higher revenue and earnings than HWH International.

Insider & Institutional Ownership

25.7% of HWH International shares are owned by institutional investors. Comparatively, 0.0% of Chugai Pharmaceutical shares are owned by institutional investors. 61.5% of HWH International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares HWH International and Chugai Pharmaceutical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
HWH International	N/A	-27.08%	-9.92%
Chugai Pharmaceutical	31.49%	20.44%	17.23%

Summary

Chugai Pharmaceutical beats HWH International on 6 of the 8 factors compared between the two stocks.

About HWH International

HWH International Inc. operates a marketplace to provide products and services for health, wealth, and happiness. The company operates through HWH Marketplace, Hapi Cafés, Hapi Travel, and Hapi Wealth Builder segments. The HWH Marketplace segment provides products manufactured by its affiliate companies at a discounted price to its members. The Hapi Cafés segment operates Hapi Cafe branded outlets in Asia, including Singapore, Republic of China (Taiwan), Hong Kong, the People's Republic of China, and South Korea. The Hapi Travel segment offers vacation packages, hotels, cruises, and other travel products for HWH members. The Hapi Wealth Builder segment focuses on exploring the options of providing services to its members through financial educational materials. The company is based in Bethesda, Maryland. HWH International Inc. operates as a subsidiary of Alset International Limited.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.